TAYSHA GENE THERAPIES INC shareholders Q2 2023

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 40 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

TAYSHA GENE THERAPIES INC shareholders Q2 2023
NameSharesValueWeighting ↓
Quantum Private Wealth, LLC 504,380$333,3960.15%
Sands Capital Ventures, LLC 724,873$478,4160.14%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 1,500,000$991,5000.11%
Nantahala Capital Management 1,251,139$827,0030.08%
Artal Group S.A. 1,440,882$9520.03%
Redwood Wealth Management Group, LLC 38,050$25,1510.03%
CARLSON CAPITAL L P 484,000$319,9240.03%
Alphabet Inc. 640,882$422,9820.02%
Camelot Portfolios, LLC 11,000$7,2710.01%
Laurion Capital Management LP 1,171,832$774,5810.00%
Sargent Investment Group, LLC 25,634$16,9440.00%
Dynamic Advisor Solutions LLC 45,000$29,7450.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 156,300$103,3140.00%
GSA CAPITAL PARTNERS LLP 18,077$120.00%
Tower Research Capital LLC (TRC) 14,435$9,5420.00%
JPMORGAN CHASE & CO 1,782$1,1780.00%
Renaissance Technologies 224,400$1480.00%
COMMONWEALTH EQUITY SERVICES, LLC 18,725$120.00%
ROYAL BANK OF CANADA 150$00.00%
Allworth Financial LP 1,000$6610.00%
External links

This page lists TAYSHA GENE THERAPIES INC's shareholders in Q2 2023. To view TAYSHA GENE THERAPIES INC's shareholder history, click here.